87907-36-6

Basic information

• Product Name: Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate
• Synonyms: Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate;((2R,3S,4R,5R,6S)-4-(benzyloxy)-5-(benzyloxycarbonylaMino)-3-hydroxy-6-Methoxytetrahydro-2H-pyran-2-yl)Methyl benzoate;1-alpha-Methyl-(2-N-benzyloxycarbonyl) -6-O-benzoyl-3-O-benzyl)-D-glucosaMine;methyl 6-O-benzoyl-3-O-benzyl-2-(benzyloxycarbonyl)amino-2-deoxy-α-D-glucopyranoside
• CAS NO: 87907-36-6
• Molecular Formula: C₂₉H₃₁NO₈
• Molecular Weight: 521.55834
• Mol File: 87907-36-6.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 688.7±55.0 °C(Predicted)
• Appearance: /
• Density: 1.29±0.1 g/cm3(Predicted)
• PKA: 10.14±0.70(Predicted)
• CAS DataBase Reference: Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate(87907-36-6)
• EPA Substance Registry System: Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate(87907-36-6)

Safety Data

• Hazardous Substances Data: 87907-36-6(Hazardous Substances Data)

Usage

Description

Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate is a complex glycoside derivative characterized by the presence of various functional groups, including a phenylmethyl group, a carbonyl group, and a benzoate ester. It is a derivative of alpha-D-glucopyranoside, which is a type of sugar molecule. The exact chemical and physical properties, uses, and safety information of this compound would require a comprehensive chemical analysis.

Uses

Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate could potentially be used in various research and industrial applications. However, specific information about its exact uses is not readily available. It may be employed in the following industries:
Used in Pharmaceutical Industry:
Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate could be used as a pharmaceutical compound for [application reason], given its complex structure and functional groups.
Used in Chemical Research:
In the field of chemical research, Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate may be utilized as a research compound for studying its chemical properties, interactions with other molecules, and potential applications.
Used in Material Science:
Methyl2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-benzoate could be explored in material science for its potential use in the development of new materials or coatings, given its unique structure and functional groups.

Upstream product

• 613-90-1 benzoyl cyanide 
• 87907-35-5 methyl 2--3-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 87907-34-4 methyl 3-O-benzyl-4,6-O-benzylidene-2-(benzyloxycarbonyl)amino-2-deoxy-α-D-glucopyranoside 
• 60076-41-7 methyl 4,6-O-benzylidene-2-(benzyloxycarbonyl)amino-2-deoxy-α-D-glucopyranoside 
• 501-53-1 benzyl chloroformate 
• 603-35-0 triphenylphosphine 

Downstream Products

• 92955-24-3 methyl 6-O-benzoyl-3-O-benzyl-2-(benzyloxycarbonyl)amino-2-deoxy-4-O-(methyl 2,4-di-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-α-D-glucopyranoside 
• 92955-25-4 methyl 6-O-benzoyl-3-O-benzyl-2-(benzyloxycarbonyl)amino-2-deoxy-4-O-(methyl 2-O-acetyl-3-O-benzyl-4-O-chloroacetyl-α-L-idopyranosyluronate)-α-D-glucopyranoside 

Relevant articles and documents

Formal Synthesis of Anticoagulant Drug Fondaparinux Sodium

The practical formal synthesis of the anticoagulant drug fondaparinux sodium 1 was accomplished using an optimized modular synthetic strategy. The important pentasaccharide 2, a precursor for the synthesis of fondaparinux sodium, was synthesized on a 10 g scale in 14 collective steps with 3.5% overall yield from well-functionalized monosaccharide building blocks. The strategy involved a convergent [3 + 2] coupling approach, with excellent stereoselectivity in every step of glycosylation from the monosaccharide building blocks. Efficient routes to the syntheses of these fully functionalized building blocks were developed, minimizing oligosaccharide stage functional-group modifications. The syntheses of all building blocks avoided rigorous reaction conditions and the use of expensive reagents. In addition, common intermediates and a series of one-pot reactions were employed to enhance synthetic efficiency, improving the yield considerably. In the monosaccharide-to-oligosaccharide assembly reactions, cheaper activators (e.g., NIS/TfOH, TESOTf, and TfOH) were used to facilitate highly efficient glycosylations. Furthermore, crystallization of several monosaccharide and oligosaccharide intermediates significantly simplified purification procedures, which would be greatly beneficial to the scalable synthesis of fondaparinux sodium.